Hematological Malignancies

Showing 1 - 25 of 96

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancies Trial in Limoges ("Blend of ginger and lemon essential oils", "Neutral oil")

Not yet recruiting
  • Hematological Malignancies
  • "Blend of ginger and lemon essential oils", "Neutral oil"
  • Limoges, France
    University Hospital, Limoges
Nov 20, 2023

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

    Not yet recruiting
    • Hematological Malignancies
    • Allogeneic T cell progenitors, cultured ex-vivo
    • (no location specified)
    Mar 2, 2023

    Hematological Malignancies Trial in Tianjin (ICP-248)

    Not yet recruiting
    • Hematological Malignancies
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 13, 2023

    Solid Tumor, Hematological Malignancies Trial in Santa Monica (Belinostat, Atazanavir)

    Recruiting
    • Solid Tumor
    • Hematological Malignancies
    • Santa Monica, California
      John Wayne Cancer Institute @ Providence Saint John's Health Cen
    Jan 31, 2023

    Hematological Malignancies Trial in Worldwide (Teclistamab)

    Recruiting
    • Hematological Malignancies
    • Birmingham, Alabama
    • +80 more
    Jan 27, 2023

    Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)

    Recruiting
    • Hematological Malignancies
    • Pembrolizumab/vibostolimab coformuation
    • Duarte, California
    • +64 more
    Jan 27, 2023

    Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)

    Completed
    • Hematological Malignancies
    • CMV Infection
    • CMV-specific T cells
    • Standard anti-viral therapy
    • Gent, Oost-Vlaanderen, Belgium
    • +7 more
    Dec 19, 2022

    Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

    Active, not recruiting
    • Hematological Malignancies
    • Duarte, California
    • +26 more
    Dec 7, 2022

    Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies Trial in Worldwide (Durvalumab / Tremelimumab Combination

    Active, not recruiting
    • Pediatric Cancer
    • +2 more
    • Durvalumab / Tremelimumab Combination Therapy
    • Baltimore, Maryland
    • +18 more
    Nov 3, 2022

    COVID19-hematological Malignancies: Italian Hematology Alliance

    Recruiting
    • SARS-CoV-2 Infection
    • Hematological Malignancies
      • Alessandria, Italy
      • +80 more
      Sep 22, 2022

      Hematological Malignancies Trial in Worldwide (Talquetamab)

      Recruiting
      • Hematological Malignancies
      • Birmingham, Alabama
      • +82 more
      Aug 11, 2022

      Hematological Malignancies Trial in Guangzhou, Tianjin (Nemtabrutinib)

      Recruiting
      • Hematological Malignancies
      • Guangzhou, Guangdong, China
      • +2 more
      Aug 10, 2022

      Adapted Physical Activity, Hematological Malignancies, Anxiety Trial (Classical APA group:, APA with Exergaming device, APA

      Not yet recruiting
      • Adapted Physical Activity
      • +3 more
      • Classical APA group:
      • +2 more
      • (no location specified)
      Jul 25, 2022

      Hematological Malignancies, Thrombocytopenia Trial in Atlanta, Decatur (EACA, Platelet transfusion)

      Terminated
      • Hematological Malignancies
      • Thrombocytopenia
      • EACA
      • Platelet transfusion
      • Atlanta, Georgia
      • +1 more
      Jun 26, 2022

      Hematological Malignancies Trial in Worldwide (Talquetamab)

      Recruiting
      • Hematological Malignancies
      • Birmingham, Alabama
      • +14 more
      Jul 14, 2022

      Hematological Malignancies Trial in Durham (fostamatinib)

      Active, not recruiting
      • Hematological Malignancies
      • Durham, North Carolina
        Duke University of Medicine
      Jul 14, 2022

      Hematological Malignancies Trial (Anti-CD7 CAR-T)

      Not yet recruiting
      • Hematological Malignancies
      • Anti-CD7 CAR-T
      • (no location specified)
      Jul 8, 2022

      Hematological Malignancies Trial in United States (KPG-818)

      Recruiting
      • Hematological Malignancies
      • Sacramento, California
      • +9 more
      Jul 4, 2022

      Advanced Solid Tumors, Hematological Malignancies Trial (ATG-018)

      Not yet recruiting
      • Advanced Solid Tumors
      • Hematological Malignancies
      • (no location specified)
      Apr 14, 2022

      Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

      Recruiting
      • Hematological Malignancies
      • +3 more
      • Phoenix, Arizona
      • +19 more
      Apr 12, 2022

      MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance (MGUS)
      • +8 more
        • Boston, Massachusetts
        • +6 more
        Apr 14, 2022

        GVHD, Hematological Malignancies Trial in Belgium (Mycophenolate mofetil, Sirolimus)

        Active, not recruiting
        • Graft-Versus-Host Disease
        • Hematological Malignancies
        • Antwerpen,, Antwerpen, Belgium
        • +12 more
        Mar 22, 2022

        Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)

        Recruiting
        • Hematological Malignancies
        • Hematopoietic Stem Cell Transplantation
        • PBSCs
        • +2 more
        • Guangzhou, Guangdong, China
          Department of Hematology,Nanfang Hospital, Southern Medical Univ
        Mar 13, 2022

        Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

        Recruiting
        • Hematological Malignancies
        • Total Body Irradiation
        • +6 more
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Feb 4, 2022